诊室内脉络膜上腔黏性固定术修复孔源性视网膜脱离
本单例报告描述了一名50余岁人工晶状体眼男性,右眼黄斑脱离的孔源性视网膜脱离,在诊室内接受脉络膜上腔透明质酸钠注射的黏性固定术。术后24小时内黄斑复位,无外层视网膜皱褶、黄斑下积液或视网膜移位,外层视网膜带快速恢复,患者术后立即恢复正常活动。作者认为该诊室内技术可行,但单例报告和短随访限制了对其获益、不良事件、失败率和最佳病例选择的判断,需进一步工作完善并评估其有效性和安全性。
要点
- 诊室内脉络膜上腔黏性固定术无需切口、无需眼内填充剂、无体位要求。
- 术后24小时内黄斑复位,无外层视网膜皱褶、残余黄斑下积液或视网膜移位。
- 单例报告短随访限制了对获益、不良事件、失败率和最佳病例选择的判断。
核心结论
- 脉络膜上腔黏性固定术作为诊室内技术创建临时脉络膜扣带以修复孔源性视网膜脱离是可行的。
- 该微创操作有潜力最大化孔源性视网膜脱离的解剖完整性和术后功能结局,因其作用机制不需要引流视网膜下液或眼内气体填充。
- 但这是单例报告且随访短,限制了判断该操作的获益、潜在不良事件、失败率和最佳病例选择的能力,需进一步工作完善操作并评估其有效性和安全性。
研究设计与样本
- 单例报告,随访时间短。
- 患者为一名50余岁男性,人工晶状体眼,近期视力下降,就诊于St Michael's Hospital, Unity Health Toronto,右眼黄斑脱离的孔源性视网膜脱离,脱离范围从6点到10点方向,未见明确致病性视网膜裂孔。
- 暴露:在疑似裂孔区域注射1%透明质酸钠于脉络膜上腔,使用30号针头及定制护套,仅暴露1 mm针头。
- 主要结局指标:能否在诊室内完成脉络膜上腔黏性固定术并获得可见的脉络膜凹陷。
主要发现
- 术后颞上区域出现圆顶状脉络膜凸起。
- 患者在不到24小时内实现黄斑复位,无术后异常如外层视网膜皱褶、残余黄斑下积液或视网膜移位,光学相干断层扫描上外层视网膜带快速恢复。
- 在脉络膜凸起区域获取的光学相干断层扫描显示黏弹性材料位于脉络膜上腔。
- 在疑似视网膜裂孔区域应用激光视网膜固定术,患者术后立即恢复正常活动,无限制。
临床怎么用
- 作者认为脉络膜上腔黏性固定术作为诊室内技术创建临时脉络膜扣带以修复孔源性视网膜脱离是可行的。
- 作者指出该微创操作有潜力最大化孔源性视网膜脱离的解剖完整性和术后功能结局,因其机制不需要引流视网膜下液或眼内气体填充。
- 作者认为需进一步工作完善操作并评估其有效性和安全性。
局限性
- 这是单例报告且随访短,限制了判断该操作的获益、潜在不良事件、失败率和最佳病例选择的能力。
- 需进一步工作完善操作并评估其有效性和安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: In-office suprachoroidal viscopexy (SCVEXY) is a minimally invasive technique for rhegmatogenous retinal detachment (RRD) repair that can be performed with no incision, no tamponade agent, and no positioning requirements. This technique has the potential to be a step forward in the armamentarium to treat RRDs. OBJECTIVE: To describe in-office SCVEXY for RRD repair. DESIGN, SETTING, AND PARTICIPANT: In this single-case report with short follow-up, a man in his 50s with pseudophakia and recent visual loss presented to St Michael's Hospital, Unity Health Toronto, with a fovea-off RRD in the right eye, extending from 6 to 10 o'clock, with no visible causative retinal break. EXPOSURE: Injection of suprachoroidal sodium hyaluronate, 1%, in the region of the suspected break, using a 30-gauge needle with a custom-made guard that exposed only 1 mm of the needle. MAIN OUTCOME AND MEASURES: Ability to perform in-office SCVEXY and to obtain a visible choroidal indentation. RESULTS: After the procedure, a dome-shaped choroidal convexity was present in the superior temporal area. The patient achieved macular reattachment in less than 24 hours with no postoperative abnormalities, such as outer retinal folds, residual subfoveal fluid, or retinal displacement, with rapid recovery of the outer retinal bands on optical coherence tomography. The optical coherence tomography scans acquired in the area of the choroidal convexity demonstrated the location of the viscoelastic material in the suprachoroidal space. Laser retinopexy was applied in the suspected region of the retinal tear, and the patient was able to resume normal activity immediately after the procedure with no restrictions. CONCLUSIONS AND RELEVANCE: Suprachoroidal viscopexy is feasible as an in-office technique to create a temporary choroidal buckle for RRD repair. It is a minimally invasive procedure with the potential to maximize anatomical outcomes of integrity and postoperative functional outcomes in RRD because its mechanism of action does not require drainage of subretinal fluid or intraocular gas tamponade. Nevertheless, this was a single-case report with short follow-up, which limits the ability to determine the procedure's benefits, potential adverse events, failure rates, and best-case selection. Further work is required to refine the procedure and assess its efficacy and safety.
引用
- Muni RH, Melo IM, Pecaku A, et al. In-Office Suprachoroidal Viscopexy for Rhegmatogenous Retinal Detachment Repair. JAMA Ophthalmol. 2023. PMID: 37615957. doi:10.1001/jamaophthalmol.2023.3785
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。